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Abstract 
AIM: There are many trials concerning peripheral nerve damage causes and treatment options. Unfortunately, 
nerve damage is still a major problem regarding health, social and economic issues. On this study, we used 
vascular graft and human cord blood derived stem cells to find an alternative treatment solution to this problem. 
MATERIAL AND METHODS: We used 21 female Wistar rats on our study. They were anesthetized with 
ketamine and we studied right hind limbs. On Group 1, we did a full layer cut on the right sciatic nerve. On Group 
2, we did a full layer cut on the right sciatic nerve, and we covered synthetic vascular graft on cut area. On Group 
3, we did a full layer cut on right sciatic nerve, and we covered the area with stem cell applied vascular graft. 
RESULTS: At the end of postoperative 8. weeks, we performed EMG on the rats. When we compared healthy 
and degenerated areas as a result of EMG, we found significant amplitude differences between the groups on 
healthy areas whereas there was no significant difference on degenerated  areas between the groups. Then we 
re-opened the operated area again to reveal the sciatic nerve cut area, and we performed electron microscope 
evaluation. On the stem cell group, we observed that both the axon and the myelin sheet prevented degeneration. 
CONCLUSION: This study is a first on using synthetic vascular graft and cord blood derived CD34+ cells in 
peripheral nerve degeneration. On  the  tissues  that  were  examined  with  electron  microscope,  we  observed  
that  CD34+  cells  prevented  both  axonal  and  myelin  sheath degeneration. Nerve tissue showed similar 
results to the control group, and the damage was minimal. 
 
 
 
 
 
 
 
 
 
Introduction 
 
Direct nerve repair with epineural micro 
sutures is still the gold Standard surgical treatment for 
severe axonotmesis and neurotmesis injuries. 
Epineural repair is performed when a tension free 
coaptation, otherwise authologus nerve grafts are 
mainly used [1] [2]. These autologous nerve grafts 
provide structural support to guide axonal 
regeneration, preventing neuroma formation and 
fibrous tissue invasion. However, there are some 
disadvantages for autologous nerve grafts as a limited 
source of the nerve grafts, permanent loss of the 
sensation at donor site [2]. Also, it may increase the 
donor site infection.  
These problems bring out the need of new 
therapeutic approaches to nerve injury. An effective 
nervous construct may require some combination of 
three primary components. However, scaffolds' results 
are not better than an autograft [1].  
Schwann cells (SCs) are peripheral glial cells 
that play a crucial role in the endogenous repair of the 
peripheral nervous system (PNS) by reconstructing 
myelin, which is necessary for functional recovery [3] 
[4]. For these reasons, SCs and Scwhann-like cells 
are one of the most widely studied cells for axonal 
regeneration and functional repair in PNS. In these 
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studies the stem cells obtained from many SCs’or 
Schwann-like cells’ sources including human umblical 
cord blood-derivered stem cells (HUCB), adipose-
derivered stem cells, bone marrow-derivered 
mesenchymal stem cells, and embriyonic stem cells 
[3] [5] [6] [7] [8]. Although adipose-derived stem cells 
have been mainly used for PNS regeneration in 
previous studies, we prefered using HUCB CD34 
positive (CD34+) stem cell because of its greater 
availability, weak immunogenicity, lower risk of graft-
versus host diseases and pluripotent differentiation, 
besides HUCBSC raises far less ethical controversies 
than  ESC  [9] [10] [11] [12]. 
In this study our aim was to examine and 
compare the effects of HUCB CD34+ stem cell and 
synthetic graft on peripheral nerve healing in an 
experimentally induced sciatic nerve injury. 
 
 
Material and Method 
 
The study was carried out in Experimental 
Research Laboratory of Faculty of Medicine at 
Pamukkale University. Approval forms were taken 
from parents of newborns from whom cord blood was 
collected. All experiments were performed in 
accordance with the guidelines for care and local 
ethical regulations established by the National 
Institutes of Health. The study used six-month-old 210 
± 30 gram (gr) Sprague-Dawley female rats. The rats 
were kept at room temperature of 22 ± 2ºC in 50% 
humid environment at 12:12 day/dark cycle during the 
experimental procedure. The subjects were divided 
into 3 groups. Group I: Control group (n = 7), sciatic 
nerve full thickness incision; Group II: vascular graft 
group (n = 7) sciatic nerve full thickness incision and 
covering lesion area with polytetrafluoroethylene 
(PTEF) type synthetic graft; Group III: stem cell group 
(n = 7) transplantation of HUCB-derived 3 X 10⁴ 
CD34
+
 stem cell into sciatic full thickness incision and 
covering the lesion with PTEF synthetic graft. 
All surgical interventions were carried out by 
the same surgeon using standard microsurgery 
methods on the sciatic nerve. Surgical operations 
were performed under anaesthesia by 50 mg/kg 
Ketamine-HCL (Alfamine®-im) and 9 mg/kg Ksilazin 
HCL (Rompun®-im) mixture. The subjects were kept 
at appropriate positions on special fixing boards for 
surgical intervention, and the operations were carried 
out under operation microscope (107 Series, Seiler 
İnstrument, St. Louis, Missouri). Operation area 
(gluteal and femur region) was shaved and surgically 
cleaned with povidone-iodine. An oblique incision was 
made in the right lower extremity in such a way to 
follow hip joint movement removing the skin and 
reaching biceps femoralis muscle. Muscle tissue was 
opened by blunt dissection, and sciatic nerve was 
exposed. The right sciatic nerve was full thickness 
incised at 1 cm proximal of separation point of tibial 
and peroneal nerves using microscissors. In all 
groups, right hind extremity was used for the study, 
while un-operated left hind extremity was kept as 
control. 
 
Collection of newborn umbilical cord 
blood, separation of CD34
+
 stem cells and 
transplantation 
A total of 50 ml of umbilical cord blood 
samples were collected from pregnant women who 
gave birth recently. It was seen that the umbilical cord 
taken was normal. Umbilical cord blood was taken 
from an umbilical vein using heparinised syringes 
immediately after leaving from newborn. Obtaining 
CD34
+
 stem cells by positive selection from the cord 
blood via using of Magnet (Magnet EasSep, StemCell 
Technologies) and magnetic nanoparticles (EasySep 
Magnetic nanoparticles 1ml, StemCell Technologies) 
was performed in 7 steps. The cells selected by 
position selection were treated with trypan blue and 
counted by hemocytometer under a light microscope. 
It was found that there were 3 x 10
4
 cells in 2μl.  
Nerve tissue sections were kept in 5% 
glutaraldehyde solution prepared with Millonig’s 
phosphate buffer for 1 hour and was dissected of 1 
mm³ on Petri covered with dental wax with 
glutaraldehyde on top using a razor. Tissue sections 
were again taken to glutaraldehyde solution and were 
fixed for 3 hours. The tissues were then shaken in 
Millonig’s phosphate buffer for 10 minutes. After 
taking the tissues in Millonig’s phosphate buffer for the 
second time, they were kept in the same tampon for a 
night. The next day, the tissues were fixed for a 
second time in 1% osmium tetraoxide solution 
prepared with Millonig’sphosphate buffer and were 
washed with phosphate tampon for 10 minutes 2 
times. Dehydrated tissue sections were then 
immersed in propylene oxide+ embedding material for 
30 minutes. Newly prepared embedding material in 
tissue sections was taken to tubes containing resin 
and was mixed in the rotator for a night. The next day, 
tissue sections were embedded into 00 polyethene 
capsules using freshly prepared embedding material 
and were polymerised at the 60ºC incubator for 48 
hours. The blocks were then removed from the 
incubator and let to cool. Cross-sections of 500 Aº 
thickness were taken from the blocks using Reichert 
Ultracut ultramicrotome. The crosssections were 
collected in 200-300 meshed copper grids and stained 
with uranyl acetate saturated in 70% ethyl alcohol and 
Reynold’s lead citrate solutions. Stained cross-
sections were analyzed in Zeiss E.M. 10 B electron 
microscope. 
In postoperative 8. Week, all rats were 
electrophysiologically evaluated using TecaMedelec 
Premiere Plus device. Active electrode was placed on 
gastrocnemius muscle of subjects, while the reference 
electrode was placed on Achilles tendon. Similar to 
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the first surgical operation, the sciatic nerve was freed 
from surrounding tissues, and sciatic nerve incision 
line was found. Nerve body was directly stimulated 
with monopolar Teflon-coated electrodes. During 
stimulation procedure, 10 mm distance was kept 
between active and reference stimulation electrodes. 
As stimulation points, the best possible distal and 
proximal points were selected in such a way to leave 
the repair line of nerve. The distance between 
proximal and distal stimulation points was measured 
with a caliper. Supra-maximal voltage was used for 
stimulation. Following the stimulation, the point where 
the first deviation from isoelectric line was marked as 
initial latency [millisecond (msn)]; peak point of axon 
was marked as peak latency [millisecond (msn)]; 
distance between positive and negative highest peaks 
was marked as amplitude [microvolt (μV)]. Compound 
muscle action potentials recorded after stimulation 
first in distal than in proximal were overlapped. The 
transmission rate of action potentials between 
proximal and distal points; peak-peak amplitude and 
area in compound muscle action potential were 
calculated. Values in experimented right and healthy 
left (control) legs were statistically compared by 
computing experimental leg/control leg ratios. 
SPSS for Windows (version 13.00) computer 
package program was used for statistical analysis. P 
value ≤ 0.05 was considered as significant. One-
Sample Kolmogorov-Smirnov Test was used to test 
the suitability of data for normal distribution. It was 
found that data was fit for normal distribution. One 
Way ANOVA Test was used to compare data. 
 
 
Results 
 
Comparison of degenerate side latency and 
amplitude values in the three groups showed no 
statistically significant difference (Table 1 and 2). 
Comparison of intra-group health and degenerated 
side latency and amplitude values showed a 
statistically significant difference. 
Table 1: EMG findings showing amplitude decrease in groups II 
and III with peripheral nerve injury  
Groups 
 
Healthy side 
amplitude values 
 
Degenerated side 
amplitude values 
X ± SD f *p
 
X ± SD f 
*
p 
Group 1 26.42 ± 7.11   23.14± 7.92       
Group 2 25.85 ± 7.33 0.012 0.988 12.28 ± 9.06           3.723 0.044
* 
Group 3 26.28 ± 7.06   16.14 ± 5.08   
* Oneway ANOVA Test; SD: standard deviation. 
Axon and myelin sheath degeneration was 
significant in lesion and untreated group (Group 1). In 
the majority of myelinated nerve fibres, the integration 
between axon and myelin sheath was lost, and gaps 
appeared. Myelin sheath was observed to be thicker 
than normal in some fibres; while the sheath was 
observed to be quite thin in others.  
In nerve fibres with thick myelin, oedema 
between the fibres was increased creating gaps in the 
myelin sheath. In degenerated nerve fibres, myelin 
sheath lost its normal order parallel array and took a 
lamellar shape in some regions.  
Table 2: EMG findings showing increased latency values in 
groups 2 and 3 with peripheral nerve injury without any 
statistically significancyroup 
Groups 
 
Healthy side  
Latency values 
 
Degenerated side 
Latency Values 
X ± SD f 
*
p
 
X ± SD f 
*
p
 
Group 1 1.22 ± 0.94   1.33 ± 0.55        
Group 2 1.20 ± 0.67 0.256 0.777 1.55 ± 0.20      2.461 0.114 
Group 3 1.22 ± 0.04   1.49 ± 0.26        
* Oneway ANOVA Test; SD: standard deviation. 
Nerve fibres with no myelin were significant in 
some regions Collagen fibres observed in latitudinal 
and longitudinal sections between the axons indicated 
an increase in connective tissue (Figure 1). 
 
Figure 1: Electron microscopic image of the untreated group. Arrow: 
the abnormal appearance of the myelin sheath, thick arrow: myelin 
sheath openings star: astrocytes, double-headed arrow: a cross-
section of collagen fibrils 
 
In-lesion group with PTEF graft application 
(Group 2), it was observed that degeneration 
continued in myelin sheath and axons, however 
significantly decreased when compared to the 
untreated group. Gaps between the myelin sheath in 
the untreated group were found to decrease in group 
3. Similarly, nerve fibres with thick myelin sheath 
observed in the untreated group were not observed in 
this group. On the other hand, connective tissue fibres 
and demonised nerve fibres were significant also in 
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this group. However they were relatively decreased 
(Figure 2). 
 
Figure 2: Electron microscopic image of vascular graft group. Arrow: 
the abnormal appearance of the myelin sheath, star: astrocytes, 
double-headed arrow: a cross-section of collagen fibrils 
 
In the group with the lesion, PTEF graft and 
human cord blood-derived CD34
+ 
stem cell (Group 3), 
general outlook was significantly positive than the 
group which was treated with vascular graft only. In 
this group, gaps observed between myelin sheath 
were lost. Nerve fibres began to take their normal 
look. Connective tissue fibres were very low in 
amount. Myelin coated nerve fibres and demyelinated 
nerve fibers were also visible in this group. Axonal 
degeneration was still present in some fibers, however 
pathological findings were significantly less found 
(Figure 3 and 4). 
 
Figure 3: Electron microscopic image of vascular grafts and cord 
blood-derived stem cells group. Arrow: myelin sheath, star, 
astrocytes 
 
Figure 4: Electron microscopic image of the control group. Arrow: 
myelin sheath, NE: blood vessel, S; cross-sectional nerve 
 
 
 
Discussion 
 
Analysis of electron microscope images of the 
groups revealed that axon and myelin sheath 
degeneration was significant in injured peripheral 
nerve in the control group, with disintegration between 
axon and myelin sheath;  gaps in majority of 
myelinous nerve fibers; edema between thick 
myelinous nerve fibers with lost of myelinous sheath 
in degenerated nerve fibers. These findings indicate 
that axon integration was damaged and endogenous 
repair mechanisms were inadequate in peripheral 
nerve injuries. In group 2 where synthetic vascular 
graft was used as treatment, it was found that 
degeneration in myelin sheath and axons continued, 
however all these findings were significantly 
decreased when compared to the control group.  
Gaps observed in myelin sheath in the control group 
were decreased in this group. In group 3 which was 
treated with vascular graft with CD34+ cells, we found 
that both axon and myelin sheath degeneration were 
prevented. It was observed that nerve tissue looked 
like the original tissue and damage decreased to a 
minimum. These findings support the view that 
umbilical cord blood-derived CD34
+
 stem cell 
transplantation can have positive effects on peripheral 
nevre injuries. 
In our study, the results obtained in the 
Control Group and the Synthetic Graft Group are 
actually not a surprise;because when the literature is 
examined it is observed that, when the axons are 
separated from the peripheric tissue with vascular 
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autograft or synthetic neural tubes, it facilitates the 
cleaning of the debris tissue which is formed due to 
the injury via SCs and macrophages in a coordination; 
then the neurotropic factors, which support the axonal 
growth,are accumulated in the tube intensely, and 
supports the healing [1] [2] [4].  
The situation in our study that creates the 
difference is that the CD34
+ 
hemopoietic stem cells 
obtained from HUCB have been used in vivo in 
neurotmesis type injuries for the first time and the 
results are positive. When the stem cell sources used 
in the repair of peripheral nerves are examined, it is 
observed that these sources are mostly in the form of 
adipose tissue, skin, bone marrow, cells that are 
similar to SCs produced with the activity of various 
growth factors in culture medium stemming from 
mesenchymal stem cells of the HUCB or the 
mesenchymal cells that contain SCs [13] [14] [15] [16] 
[17]. Recently mesenchymal stromal cells (MSC), 
have become the focus of attention for the treatment 
of nerve injury, owing to their positive effects in the 
regeneration process  [18] [19] In a recent study 
Sanchez et al. showed that murine and canine Ad-
MSC associated with decellularized vein scaffold had 
positive effects on sciatic nerve regeneration in a rat 
model [18]. The most proper time for repairing the 
damage after peripheric nerve injuries are the shortest 
time possible after the injury [1] [20]. The conversion 
of stem cells obtained from various sources into 
Schwann-like stem cells in culture medium requires 
time, and obtaining stem cell from bone marrow 
originating from mesenchyme is an extremely invasive 
method posing another disadvantage [2] [3] [9]. Also, 
to repair the injury in peripheral nerve injuries as soon 
as possible, the stem cell to be obtained must be 
quick to obtain, must be able to be used freshly, must 
be easily available in big amounts and not pose any 
risks in the donor during or after the process. The 
stem cells obtained from the HUCB blood may be 
considered as the most suitable source for the above 
mentioned criteria.  
CD34
+ 
hemopoietic stem cells obtained from 
the HUCB were examined both in vitro and in vivo 
media many times regarding their central system 
stroke models and spinal cord trauma models. In such 
study conducted by Nishino et al., [21]. It was reported 
that the CD34
+ 
stem cells obtained from HUCB were 
used in spinal cord trauma models and that these 
transplanted cells lived for at least 3 weeks; however, 
disappeared completely after 5 weeks. Also, it was 
also reported in the same study that the transplanted 
CD34
+ 
stem cells increased functional healing in rats. 
In addition to these findings, the transplanted CD34
+ 
stem cells did not express the neuronal lineage 
markers. Kao et al., [12]. Conducted another study 
with spinal cord trauma and reported that when the 
CD34
+ 
stem cells stemming from HUCB were given 
systemically, the Glial delivered neurotropic factor 
(GDNF) and the Vascular Endothelial Growth Factor 
(VEGF) amount in the cord; and that when the 
opposite practice was applied with CD34
- 
stem cells 
obtained from the HUCB and saline,there were no 
significant increase observed in the GDNF and VEGF 
in the injured cord. In the light of these findings, they 
reported that the CD34
+ 
stem cells obtained from 
HUCB increased the hind leg functions of the rats with 
the restoration of the injured cord and with the GDNF 
and VEGF production. It is known that the GDNF has 
a potent survival factor characteristics for 
mesencephalic dopaminergic neurons and motor 
neurons; and that the VEGF increases the 
neovascularization in the ischemic zone [12]. 
There have been many in vitro studies 
conducted to examine the effects of the CD34
+ 
stem 
cells on the recovery of nerves. The CD34
+ 
hemopoietic stem cells stemming from the HUCB 
were used in these studies. In one of these in vitro 
studies conducted by Fan et al., [22], CD34
+ 
stem 
cells obtained from the HUCB were used, and it was 
reported that the fibronectin (Fn) accelerated the 
endothelial cell (EC) differentiation which has the Flk-
1, vWF surface markers of the CD34
+ 
stem cells. 
Bracci-Laudiero et al. [23]. Conducted a two-color flow 
cytometry study and reported that CD34
+ 
stem cells 
obtained from the HUCB expressed the NGF and the 
TrkA which is its specific receptor; however, they also 
reported that these stem cells did not express the P75 
which is known as the pan-neurotrophin receptor and 
which is a member of the Tumour Necrosis Factor 
(TNF) receptor superfamily. However, the P75 
receptor binds with all neurotrophins in a similar 
affinity but in different kinetics. On the contrary, the 
Trk family receptors are highly specific [24].  
In our study, the CD34
+ 
hemopoietic stem 
cells obtained from the HUCB protected the axon and 
myelin sheath from degeneration. We consider that 
this regeneration occurs with the stem cells producing 
various neurotrophic factors and neurotrophins, 
minimizing the effect of the injury in the PNS, and 
supporting the SCs, and this situation is not contrary 
to the literature, because it is known that after 
neurotmesis type injury, in order to repair the wound, 
the SCs express neurotrophin and extracellular matrix 
protein such as NGF, BDNF, Neurotrophin-3 (NT-3), 
Neurotrophin 4/5 (NT-4/5), CTNF, TGF-1b, and bFGF; 
provided extracellular matrix products such as 
fibronectin,laminin, tenascin-C, type IV and type V 
collagen, heparin sulfate and chondroitin sulfate 
proteoglycan and also express adhesion molecules 
such as NCAM, L1 and N-cadherin [2] [4] [24] . Also, 
in a study conducted by Fan et al., [25]., it was 
reported that the mononuclear cells obtained from 
HUCB expressed BDNF, NGF, GDNF, NT-3 and NT-5 
mRNA. In addition to this, the fact that the CD34
+ 
stem 
cells obtained from the HUCB including many different 
subgroup cells like multi-potent and lineage-
committed progenitor cell type support this viewpoint. 
Another interesting situation is that although 
the end-to-end anastomosis or SCs obtained from 
different sources or stem cells are planted to the injury 
 Yilmaz et al. Vascular Graft and Human Umbilical Cord Blood-Derived CD34+ Stem Cell on Peripheral Nerve Healing 
_______________________________________________________________________________________________________________________________ 
_______________________________________________________________________________________________________________________________ 
Open Access Maced J Med Sci. 2018 Nov 25; 6(11):1946-1952.                                                                                                                                                 1951 
 
area after PNS injury, the growth speed in the injured 
nerves does not change. Although this situation 
seems like a paradox, in fact, it coincides with the 
hypothesis that the stem cells express various growth 
factors and support the SCs, because the injury in 
peripheric nerve injuries occur not in the nerve body 
but the axon in the nerve extension; and when it is 
considered that the growth of the axons is under the 
control of the genes which are in the cell nucleus, the 
situation which seems like a paradox is in fact not 
contrary to the literature. This situation supports the 
hypothesis that the stem cells support the SCs. 
In our study, it was observed that this healing 
effect was not reflected in the amplitude and latency 
values in the EMG. The results of the EMG having 
been obtained like this in our study may be due to one 
reason. The EMG having been performed without 
reaching the end organ after the recovery of the 
nerve. We believe EMG findings may reveal the effect 
of healing process in the chronic phase. Further  
studies about stem cell treatment both in acute and 
chronic phase of peripheral nerve injury may also 
show better EMG findings suggesting lower axonal 
loss.  
There are limitations of our study. First of all 
we didn't study any biochemical markers and 
neurotrophic factors to examine the effect of stem cell 
and underlying mechanism of the healing process. 
Additionally not only the acute but also the chronic 
phase EMG findings may be helpfull.   
In conclusion, although how the CD34
+ 
stem 
cells obtained from the HUCB support the 
regeneration and prevent the degeneration is not clear 
much, the findings makes us consider that the CD34
+ 
stem cells obtained from the HUCB support this via 
various neurotrophic factors. To determine the 
mechanisms clearly, further studies are necessary. 
Obtaining stem cells from HUCB in a fast and easy 
way may provide an advantage in repairing the PNS 
injuries in the early period. 
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